Title: | Improving the understanding of how patients with non-dystrophic myotonia are selected for myotonia treatment with mexiletine (NaMuscla): outcomes of treatment impact using a European Delphi panel |
Journal : | BMC neurology, 21, 1 |
Authors: | Chapman AM ; Schurer M ; Weijers L ; Omar A ; Lee H ; Weidenfeller AZ ; Ellis C ; Sonecha S ; Schneider-Gold C |
Material Type: | Article |
Publication Date: | 01/12/2021 |
Size: | p 467 |
Languages: | English |
Keywords : | adulthood ; disease natural history ; guidelines ; health care management ; ion channel disease ; medical treatment ; mexiletine ; non dystrophic myotonic disease ; quality of life |
Keywords: | Delphi panel;EQ-5D;Healthcare resource utilisation;INQoL;Mexiletine (NaMuscla);Non-dystrophic myotonia;Quality of life; |
Lien associé : | Texte complet disponible sur PubMed Central (PMC) |
Pubmed / DOI : | Pubmed : 34852780 / DOI : 10.1186/s12883-021-02491-3 |
N° Profil MNM : | 2021113 |
Link for e-copy: | http://www.ncbi.nlm.nih.gov/pubmed/34852780 |
See also : |